Clinical trials with ALS patients showed that Riluzole lengthens survival by several months, and may have a greater survival benefit for those with a bulbar onset.
Riluzole lengthens survival by several months in ALS patients in clinical trials. It may have increased benefits in patients with bulbar onset.